| Year |
Citation |
Score |
| 2022 |
Faridar A, Vasquez M, Thome AD, Yin Z, Xuan H, Wang JH, Wen S, Li X, Thonhoff JR, Zhao W, Zhao H, Beers DR, Wong STC, Masdeu JC, Appel SH. Ex vivo expanded human regulatory T cells modify neuroinflammation in a preclinical model of Alzheimer's disease. Acta Neuropathologica Communications. 10: 144. PMID 36180898 DOI: 10.1186/s40478-022-01447-z |
0.328 |
|
| 2022 |
Thome AD, Thonhoff JR, Zhao W, Faridar A, Wang J, Beers DR, Appel SH. Extracellular Vesicles Derived From Expanded Regulatory T Cells Modulate and Inflammation. Frontiers in Immunology. 13: 875825. PMID 35812435 DOI: 10.3389/fimmu.2022.875825 |
0.388 |
|
| 2021 |
Thome AD, Atassi F, Wang J, Faridar A, Zhao W, Thonhoff JR, Beers DR, Lai EC, Appel SH. Ex vivo expansion of dysfunctional regulatory T lymphocytes restores suppressive function in Parkinson's disease. Npj Parkinson's Disease. 7: 41. PMID 33986285 DOI: 10.1038/s41531-021-00188-5 |
0.574 |
|
| 2019 |
Faridar A, Thome A, Zhao W, Pascual B, Victoria A, Dlouhy KG, Beers D, Masdeu JC, Appel S. P2-187: TARGETING ADAPTIVE IMMUNE SYSTEM IN ALZHEIMER'S DISEASE Alzheimer's & Dementia. 15: P648-P648. DOI: 10.1016/J.Jalz.2019.06.2594 |
0.365 |
|
| 2018 |
Williams GP, Schonhoff AM, Jurkuvenaite A, Thome AD, Standaert DG, Harms AS. Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson's disease. Journal of Neuroinflammation. 15: 244. PMID 30165873 DOI: 10.1186/S12974-018-1286-2 |
0.648 |
|
| 2017 |
Harms AS, Delic V, Thome AD, Bryant N, Liu Z, Chandra S, Jurkuvenaite A, West AB. α-Synuclein fibrils recruit peripheral immune cells in the rat brain prior to neurodegeneration. Acta Neuropathologica Communications. 5: 85. PMID 29162163 DOI: 10.1186/S40478-017-0494-9 |
0.743 |
|
| 2017 |
Harms AS, Thome AD, Yan Z, Schonhoff AM, Williams GP, Li X, Liu Y, Qin H, Benveniste EN, Standaert DG. Peripheral monocyte entry is required for alpha-Synuclein induced inflammation and Neurodegeneration in a model of Parkinson disease. Experimental Neurology. PMID 29155051 DOI: 10.1016/j.expneurol.2017.11.010 |
0.657 |
|
| 2016 |
Thome AD, Harms AS, Volpicelli-Daley LA, Standaert DG. microRNA-155 Regulates Alpha-Synuclein-Induced Inflammatory Responses in Models of Parkinson Disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 36: 2383-90. PMID 26911687 DOI: 10.1523/Jneurosci.3900-15.2016 |
0.734 |
|
| 2016 |
Ponnazhagan R, Harms AS, Thome AD, Jurkuvenaite A, Gogliotti R, Niswender CM, Conn PJ, Standaert DG. The Metabotropic Glutamate Receptor 4 Positive Allosteric Modulator ADX88178 Inhibits Inflammatory Responses in Primary Microglia. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. PMID 26872456 DOI: 10.1007/S11481-016-9655-Z |
0.748 |
|
| 2015 |
Thome AD, Standaert DG, Harms AS. Fractalkine Signaling Regulates the Inflammatory Response in an α-Synuclein Model of Parkinson Disease. Plos One. 10: e0140566. PMID 26469270 DOI: 10.1371/journal.pone.0140566 |
0.786 |
|
| 2013 |
Harms AS, Cao S, Rowse AL, Thome AD, Li X, Mangieri LR, Cron RQ, Shacka JJ, Raman C, Standaert DG. MHCII is required for α-synuclein-induced activation of microglia, CD4 T cell proliferation, and dopaminergic neurodegeneration. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 9592-600. PMID 23739956 DOI: 10.1523/Jneurosci.5610-12.2013 |
0.776 |
|
| Show low-probability matches. |